Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Avid Bioservices, Inc.
Avid Bioservices, Inc. News
Mar 23, 2025 - prnewswire.com
WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year
Mar 17, 2025 - prnewswire.com
Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025
Mar 17, 2025 - globenewswire.com
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
Feb 24, 2025 - accessnewswire.com
The Schall Law Firm Invites Shareholders With Losses In Avid Bioservices, Inc. To Join A Securities Fraud Investigation
Avid Bioservices, Inc. Quantitative Score
About Avid Bioservices, Inc.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Avid Bioservices, Inc. Earnings & Revenue
Avid Bioservices, Inc. Financials
Table Compare
Compare CDMO metrics with: | |||
|---|---|---|---|
Earnings & Growth | CDMO | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | CDMO | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | CDMO | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | CDMO | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Avid Bioservices, Inc. Income
Avid Bioservices, Inc. Balance Sheet
Avid Bioservices, Inc. Cash Flow
Avid Bioservices, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Avid Bioservices, Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 0.6600 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2018-04-02 | 0.66 | Quarterly |
Avid Bioservices, Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Avid Bioservices, Inc. Executives
| Name | Role |
|---|---|
| Mr. Nicholas Stewart Green B.Sc., MBA | President, Chief Executive Officer & Director |
| Mr. Daniel R. Hart | Chief Financial Officer |
| Mr. Mark R. Ziebell J.D. | Vice President, General Counsel & Corporate Secretary |
| Mr. Richard A. Richieri | Chief Operations Officer |
| Mr. Matthew R. Kwietniak | Chief Commercial Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Nicholas Stewart Green B.Sc., MBA | President, Chief Executive Officer & Director | Male | 1965 | 699.01K |
| Mr. Daniel R. Hart | Chief Financial Officer | Male | 1973 | 497.16K |
| Mr. Mark R. Ziebell J.D. | Vice President, General Counsel & Corporate Secretary | Male | 1964 | 477.16K |
| Mr. Richard A. Richieri | Chief Operations Officer | Male | 1965 | 411.91K |
| Mr. Matthew R. Kwietniak | Chief Commercial Officer | Male | 1969 | 409.43K |
Avid Bioservices, Inc. Insider Trades
| Date | 5 Feb |
| Name | Ziebell Mark R |
| Role | V. P., General Counsel |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 66799 |
| Date | 5 Feb |
| Name | Ziebell Mark R |
| Role | V. P., General Counsel |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 14286 |
| Date | 5 Feb |
| Name | Ziebell Mark R |
| Role | V. P., General Counsel |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 21429 |
| Date | 5 Feb |
| Name | Ziebell Mark R |
| Role | V. P., General Counsel |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 98120 |
| Date | 5 Feb |
| Name | Ziebell Mark R |
| Role | V. P., General Counsel |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 55310 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 5 Feb | Ziebell Mark R | V. P., General Counsel | Disposed | D-Return | 66799 |
| 5 Feb | Ziebell Mark R | V. P., General Counsel | Disposed | D-Return | 14286 |
| 5 Feb | Ziebell Mark R | V. P., General Counsel | Disposed | D-Return | 21429 |
| 5 Feb | Ziebell Mark R | V. P., General Counsel | Disposed | D-Return | 98120 |
| 5 Feb | Ziebell Mark R | V. P., General Counsel | Disposed | D-Return | 55310 |